CEPH Message Board - Msg: 1379864

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rudy Saucillo who wrote (248)	5/10/1997 8:17:00 PM
From: harkenman	of 998

Sell your shares. Myo has no chance. Its not patent protected, none of the big guys will touch it, the $130Million sent to date is the cost of research. The FDA will not approve this drug based on the studies. CEPH denial to supply drug to the total 400 patients in the t-IND is an approach to pressure the FDA to get approval. It will not work. Rilutek is a $25Million/year prodcut and its approved in 20 countries. What price will ceph charge to recover their investment? Have you done the ROI/cash flows/IRR analysis? CEPH has indicated in their SEC filing if they do not get apporval they will discontinue the filing process.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next